Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Management of Severe Hyperglycemia

Immediate Assessment and Diagnosis

  • The American Diabetes Association recommends checking arterial blood gases, complete blood count, urinalysis, plasma glucose, electrolytes, BUN, creatinine, and obtaining an ECG immediately for patients with glucose levels >400 mg/dL 1
  • DKA criteria include pH <7.3, bicarbonate <15 mEq/L, moderate ketonuria/ketonemia, according to the American Diabetes Association 1
  • HHS criteria include pH >7.3, bicarbonate >15 mEq/L, effective serum osmolality >320 mOsm/kg, as defined by the American Diabetes Association 1
  • Calculated corrected sodium should be determined by adding 1.6 mEq to measured sodium for each 100 mg/dL glucose above 100 mg/dL, as recommended by the American Diabetes Association 1

Fluid Resuscitation Protocol

  • The American Diabetes Association recommends starting with 0.9% normal saline at 10-20 ml/kg/hour (approximately 1-1.5 liters in the first hour for adults) for fluid resuscitation 1
  • In severely dehydrated patients, the American Diabetes Association suggests repeating this bolus, but not exceeding 50 ml/kg over the first 4 hours 1
  • Fluid therapy should be continued at 1.5 times the 24-hour maintenance requirements (approximately 5 ml/kg/hour) to replace deficit evenly over 48 hours, according to the American Diabetes Association 1
  • The American Diabetes Association recommends switching to 0.45-0.9% NaCl based on corrected serum sodium levels, ensuring osmolality decrease does not exceed 3 mOsm/kg/H2O per hour 1

Insulin Therapy

  • The American Diabetes Association recommends giving an initial IV bolus of regular insulin at 0.15 units/kg body weight for adults with severe hyperglycemia (>400 mg/dL) 1
  • Continuous infusion of regular insulin at 0.1 units/kg/hour (typically 5-7 units/hour in adults) is recommended by the American Diabetes Association and The Lancet Diabetes and Endocrinology 1, 3
  • The American Diabetes Association recommends targeting a glucose decline of 50-75 mg/dL per hour 1
  • If glucose does not fall by 50 mg/dL in the first hour, the American Diabetes Association suggests verifying adequate hydration, then doubling the insulin infusion rate hourly until achieving steady decline 1

Potassium Management

  • The Lancet Diabetes and Endocrinology reports that hypokalemia occurs in approximately 50% of patients during treatment and severe hypokalemia (<2.5 mEq/L) increases mortality 3
  • The American Diabetes Association recommends adding 20-40 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO4) once renal function is confirmed and serum potassium is known 1
  • The American Diabetes Association advises not starting insulin if potassium is <3.3 mEq/L until potassium is repleted 1
  • The Lancet Diabetes and Endocrinology recommends monitoring potassium levels closely throughout treatment 3

Setting-Specific Considerations

  • The Lancet Diabetes and Endocrinology suggests maintaining glucose between 140-180 mg/dL once IV insulin is initiated for critically ill patients (ICU setting) 3
  • The American Diabetes Association recommends using validated computerized or written protocols for insulin infusion adjustments in the ICU setting 4
  • The Lancet Diabetes and Endocrinology advises avoiding glucose targets <110 mg/dL due to increased hypoglycemia risk 3

Transition to Subcutaneous Insulin

  • The American Diabetes Association recommends starting subcutaneous basal insulin 1-2 hours before stopping IV infusion when discontinuing IV insulin after glucose stabilization 4
  • The American Diabetes Association suggests calculating basal insulin dose as 60-80% of total daily IV insulin dose 4
  • The American Diabetes Association recommends using half of the 24-hour IV insulin total as long-acting basal insulin, and dividing the other half by 3 for rapid-acting insulin doses before meals 4

Common Pitfalls to Avoid

  • The American Diabetes Association strongly discourages using sliding-scale insulin alone, as it is associated with poor outcomes 5
  • The Lancet Diabetes and Endocrinology advises avoiding overly aggressive glucose lowering, as targets <110 mg/dL increase hypoglycemia risk and mortality 3
  • The American Diabetes Association recommends not stopping IV insulin abruptly, ensuring 1-2 hour overlap with subcutaneous insulin to prevent rebound hyperglycemia 4
  • The American Diabetes Association suggests monitoring mental status closely, as rapid changes may indicate cerebral edema (especially in younger patients) or iatrogenic complications 1
  • The American Diabetes Association recommends reassessing insulin regimen if glucose falls below 100 mg/dL and modifying when <70 mg/dL unless explained by missed meals 4